Literature DB >> 2429234

Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes.

K Selmaj, C Plater-Zyberk, K A Rockett, R N Maini, R Alam, G D Perkin, F C Rose.   

Abstract

The percentage of interleukin-2-receptor-positive peripheral blood lymphocytes in MS patients was significantly higher in acute relapse than in remission or in controls. After stimulation by phytohemagglutinin, the expression of interleukin-2 receptor on peripheral blood lymphocytes of MS patients was within the range of healthy controls, implying no general impairment of receptor expression. These results confirm other evidence that there is a small population of activated T lymphocytes in acute relapse of MS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429234     DOI: 10.1212/wnl.36.10.1392

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

2.  Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.

Authors:  A D Crockard; T A McNeill; J McKirgan; S A Hawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

Review 3.  Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials.

Authors:  P S Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

4.  CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.

Authors:  A Salmaggi; L LaMantia; C Milanese; G Bianchi; M Eoli; A Campi; A Nespolo
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

5.  Correlation of -475 IL-2 Promoter Gene Polymorphisms and the Levels of Serum IL-2 on the Risk of Multiple Sclerosis.

Authors:  Thekra Abdulaali Abed; Anwar Ali Abdulla
Journal:  Rep Biochem Mol Biol       Date:  2022-04

6.  Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

Authors:  C Plater-Zyberk; K A Rockett; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

7.  Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

8.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

9.  Memory and naive CD4+ lymphocytes in multiple sclerosis.

Authors:  A M Porrini; D Gambi; G Malatesta
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.